4-METHYL-N-(3-(5-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)BENZAMIDE
UNII N96A6U3MBC
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-methyl-n-(3-(5-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N96A6U3MBC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 641571-15-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H22F3N7O LVVDYLLEWIHKDY-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-methyl-n-(3-(5-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.